Immunoglobulin G Fc N-glycosylation in Guillain-Barré syndrome treated with intravenous immunoglobulin

Glycosylation as a marker for inflammatory arthritis

(2017) Simone Albrecht et al.   Cancer Biomarkers

IgG Fc N-Glycosylation in Guillain–Barré Syndrome Treated with Immunoglobulins

(2014) Willem-Jan R. Fokkink et al.   JOURNAL OF PROTEOME RESEARCH

Sialylation of Campylobacter jejuni Endotoxin Promotes Dendritic Cell-Mediated B Cell Responses through CD14-Dependent Production of IFN-  and TNF- 

(2013) R. Huizinga et al.   JOURNAL OF IMMUNOLOGY

Association between Galactosylation of Immunoglobulin G and Improvement of Rheumatoid Arthritis during Pregnancy Is Independent of Sialylation

(2013) Albert Bondt et al.   JOURNAL OF PROTEOME RESEARCH

Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome

(2009) Krista Kuitwaard et al.   ANNALS OF NEUROLOGY

Terminal sugars of Fc glycans influence antibody effector functions of IgGs

(2008) T Shantha Raju   CURRENT OPINION IN IMMUNOLOGY

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome

(2008) Pieter A van Doorn et al.   LANCET NEUROLOGY

Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc

(2008) R. M. Anthony et al.   SCIENCE